Tibotec, FDA Update Warning Label On HIV Drug’s Risk Of Severe Skin Reaction
Tibotec Therapeutics, a unit of Johnson & Johnson, “has strengthened a warning about serious skin reactions in patients treated with the company’s HIV drug Intelence,” the FDA and the company said on Wednesday, Reuters reports.
Also tagged Amp, Fda, Hiv, Hiv Drug, Reuters, Serious Skin, Skin Reaction, Skin Reactions, Tibotec Therapeutics
